This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2000 Feb 23;283(8):1055-6.

doi: 10.1001/jama.283.8.1055.

Estrogen and Alzheimer disease: plausible theory, negative clinical trial

B A Shaywitz, S E Shaywitz

PMID: 10697067
DOI: 10.1001/jama.283.8.1055

Editorial

Estrogen and Alzheimer disease: plausible theory, negative clinical trial

B A Shaywitz et al. JAMA. 2000.

. 2000 Feb 23;283(8):1055-6.

doi: 10.1001/jama.283.8.1055.

Authors

B A Shaywitz, S E Shaywitz

PMID: 10697067
DOI: 10.1001/jama.283.8.1055

No abstract available

PubMed Disclaimer

Comment on

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ. Mulnard RA, et al. JAMA. 2000 Feb 23;283(8):1007-15. doi: 10.1001/jama.283.8.1007. JAMA. 2000. PMID: 10697060 Clinical Trial.

Similar articles

Estrogen in cognetive behaviors--clinical application of estrogen for dementia of Alzheimer type.
Hagino N. Hagino N. Acta Biol Hung. 1994;45(2-4):233-47. Acta Biol Hung. 1994. PMID: 7725820 Review.
Estrogen as a treatment for Alzheimer disease.
Toran-Allerand CD. Toran-Allerand CD. JAMA. 2000 Jul 19;284(3):307-8. JAMA. 2000. PMID: 10891957 No abstract available.
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia.
Yaffe K, Sawaya G, Lieberburg I, Grady D. Yaffe K, et al. JAMA. 1998 Mar 4;279(9):688-95. doi: 10.1001/jama.279.9.688. JAMA. 1998. PMID: 9496988
[Estrogens and Alzheimer's disease: rationale, promises, and facts].
Martínez Lage JM, Oliveros-Cid A, Martínez-Lage P. Martínez Lage JM, et al. Med Clin (Barc). 2000 May 20;114(19):747-55. Med Clin (Barc). 2000. PMID: 10919131 Review. Spanish. No abstract available.
Estrogen as a psychotherapeutic agent.
Rodriguez MM, Grossberg GT. Rodriguez MM, et al. Clin Geriatr Med. 1998 Feb;14(1):177-89. Clin Geriatr Med. 1998. PMID: 9456341 Review.

See all similar articles

Cited by

Therapeutic approaches to age-associated neurocognitive disorders.
O'Hara R, Derouesné C, Fountoulakis KN, Yesavage JA. O'Hara R, et al. Dialogues Clin Neurosci. 2001 Sep;3(3):191-213. doi: 10.31887/DCNS.2001.3.3/rohara. Dialogues Clin Neurosci. 2001. PMID: 22033831 Free PMC article.
Neuroprotective actions of selective estrogen receptor modulators.
DonCarlos LL, Azcoitia I, Garcia-Segura LM. DonCarlos LL, et al. Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S113-22. doi: 10.1016/j.psyneuen.2009.04.012. Psychoneuroendocrinology. 2009. PMID: 19447561 Free PMC article.
The Role of Estrogen Therapy as a Protective Factor for Alzheimer's Disease and Dementia in Postmenopausal Women: A Comprehensive Review of the Literature.
Ali N, Sohail R, Jaffer SR, Siddique S, Kaya B, Atowoju I, Imran A, Wright W, Pamulapati S, Choudhry F, Akbar A, Khawaja UA. Ali N, et al. Cureus. 2023 Aug 6;15(8):e43053. doi: 10.7759/cureus.43053. eCollection 2023 Aug. Cureus. 2023. PMID: 37680393 Free PMC article. Review.

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information